The terms topographic diagnosis and localization refer to the same exercise: identifying where in the nervous system a lesion lies. The clinical examination, interpreted in the context of neuroanatomy, almost always points to one site or a discrete set of sites. But not all neurologic diseases produce single, discrete lesions — some affect systems of neurons spread across multiple anatomic locations. This distinction between discrete (focal) lesions and system (degenerative) lesions changes how we localize and what differential we generate. This page covers the principles of topographic diagnosis and how the distinction shapes our thinking.

Discrete vs System Lesions

Discrete Lesions

A discrete lesion is one identifiable abnormality at a specific anatomic location. The classical examples:

• Stroke: an arterial territory or a small perforator distribution is infarcted, producing a sharp focal deficit. Recognizing the territory points to the artery; recognizing the artery points to the mechanism.
• Tumor: a glioma, meningioma, or metastasis occupying a specific location, producing dysfunction of that region and adjacent structures.
• Trauma: a contusion in a specific location of the cortex or cord, often at impact site (coup) or opposite side (contrecoup).
• Demyelinating plaque: in MS, a single plaque in a specific tract can produce a discrete syndrome (optic neuritis, partial transverse myelitis).
• Infection: a brain abscess at a specific location.

For discrete lesions, the question is: where is it? The exam directly points to the site, and imaging confirms. Discrete lesions tend to produce sharp, well-circumscribed deficits.

System Lesions

A system lesion is one in which a specific functional system of neurons is affected throughout its anatomic distribution. The damage is not at one location — it is in the whole class of neurons that share a functional role, often defined molecularly, metabolically, or by neurotransmitter system. Classical examples:

• Parkinson disease: degeneration of dopaminergic neurons of the substantia nigra pars compacta. The lesion is at the substantia nigra, but the dysfunction is throughout the dopaminergic system the SN feeds.
• Amyotrophic lateral sclerosis (ALS): progressive death of upper motor neurons in the motor cortex and lower motor neurons in the anterior horn and motor nuclei, throughout the neuraxis.
• Spinocerebellar ataxias: degeneration of cerebellar Purkinje cells and other interconnected structures depending on the specific SCA.
• Subacute combined degeneration from B12 deficiency: dorsal columns + corticospinal tracts — two long, large-fiber systems affected together throughout their length.
• Vitamin E deficiency or abetalipoproteinemia: large dorsal root ganglion neurons, with secondary dorsal column degeneration.
• Alzheimer disease: cortical degeneration starting in the entorhinal cortex and hippocampus, spreading through limbic and cortical association areas — affecting a functional cognitive network.
• Friedreich ataxia: dorsal root ganglia, dorsal columns, spinocerebellar tracts, and corticospinal tracts — all the long tracts that share certain metabolic vulnerabilities.
• Lewy body dementia: cortical and subcortical neurons that share α-synuclein pathology.
• Frontotemporal dementia: frontal and temporal cortices with TDP-43, tau, or other proteinopathies.

For system lesions, the question is: which system is affected? The signs reflect the function of the affected neuron class, and the lesion is in that class wherever those neurons live.

How the Distinction Shapes Differential Diagnosis

The topographic diagnosis approach has different implications:

The Hybrid Pattern

Some processes blur the line:

• Multiple sclerosis: discrete plaques (focal), but multiple lesions scattered in space and time can mimic a system disease.
• Paraneoplastic syndromes: autoimmune attack on neuronal antigens can produce both syndromes affecting specific systems (limbic encephalitis, cerebellar degeneration) and discrete features.
• Infections: can be focal (abscess) or diffuse (encephalitis affecting multiple regions).
• Mitochondrial disease: tends to affect tissues with high energy demand — basal ganglia, cerebellum, optic nerves, muscles — in patterns that often look like multi-system disease.

The Topographic Approach Step by Step

Step 1: Recognize Impaired Function

The clinical examination identifies what is not working. This requires a complete neurologic examination — mental status, cranial nerves, motor, sensory, reflexes, coordination, gait. A deficit cannot be localized if it has not been detected.

Step 2: Ask “Where Is the Lesion?”

Map each abnormal finding back to its neuroanatomic substrate. A lesion that affects two structures must lie where those structures intersect. Some patterns are so distinctive that the lesion can be named at the bedside:

• Right face/arm weakness + aphasia → left frontal cortex.
• Left hemiparesis + right third nerve palsy → right midbrain (Weber syndrome).
• Right facial weakness + left limb weakness → left pons (Millard-Gubler).
• Ipsilateral face / contralateral body pain-temperature loss → lateral medulla (Wallenberg).

Step 3: Ask “Discrete or System?”

Insidious progression of multiple related deficits across the neuraxis suggests a system process. Acute onset of a focal pattern suggests a discrete process. Both possibilities should be entertained when the picture is ambiguous.

Step 4: Generate Differential

Discrete focal deficit, acute onset → stroke at top of list. Subacute → tumor, abscess, demyelination. Insidious + focal → tumor.

System pattern, insidious onset → neurodegenerative process. Look for specific patterns (motor and sensory long tracts → SCD; nigrostriatal → Parkinson; pure motor → ALS).

Step 5: Imaging and Ancillary Testing

Imaging usually confirms a discrete lesion. System lesions are often imaged to show atrophy or rule out a discrete lesion; the diagnosis often rests on the clinical syndrome plus targeted testing (genetic, biochemical, immunologic).

Common Topographic Patterns and Their Anatomic Implications

The Role of History in Localization

Although the neurologic examination is the primary localizing tool, the history shapes interpretation. The history tells us:

• Tempo: minutes to hours = vascular; days to weeks = inflammatory/infectious; months to years = degenerative or slow tumor; episodic = epileptic, vascular, migrainous.
• Progression: stepwise = repeated discrete events; smooth progression = continuous process; relapsing = MS or other autoimmune.
• Associated systemic features: fever, weight loss, cancer history.
• Family history: hereditary disorders.
• Exposures: alcohol, drugs, toxins, occupational, dietary.

The history especially helps decide between localization possibilities that the exam allows. A right hemiparesis could be left MCA, left subcortical, left brainstem, or even a left cortical seizure with postictal Todd paralysis — the history of acute onset versus episodic versus subacute helps distinguish.

Levels of Localization — Working from the Periphery Inward

A useful framework: try to localize to the lowest possible level, then climb up only if findings require it.

1. Muscle: pure proximal symmetric weakness, no sensory, no reflex change (or reflexes diminished proportional to weakness). Usually elevated CK.
2. NMJ: fatigable weakness, often with ocular or bulbar involvement. Reflexes preserved.
3. Peripheral nerve: weakness, sensory, reflex change in the distribution of one or more nerves.
4. Plexus: similar but involves multiple nerves from one plexus.
5. Root: dermatomal sensory, myotomal motor, reflex change at one or two levels.
6. Spinal cord: sensory level, bilateral or hemibody motor below the level, bladder/bowel involvement.
7. Brainstem: crossed signs (ipsilateral cranial nerve, contralateral body).
8. Cerebellum: ataxia, dysmetria — ipsilateral.
9. Diencephalon (thalamus, hypothalamus): hemibody sensory, behavioral, endocrine.
10. Subcortical (capsule, white matter): motor without cortical features; varied syndromes.
11. Cortex: cortical features (aphasia, neglect, apraxia, seizures, cortical sensory loss).

Start at the bottom of this list; climb only as the findings dictate. A pure motor weakness in a stocking-glove distribution does not need to invoke cortical localization.

Lesions at the Intersection

Many of the most useful localizing signs in neurology arise because two pathways pass through one specific anatomic spot together. A lesion at that spot affects both. Examples:

• Internal capsule: corticospinal + corticobulbar fibers running close together → pure motor hemiparesis affecting face, arm, leg equally.
• Anterior choroidal artery territory: posterior limb of internal capsule (motor) + thalamus (sensory) + optic tract (vision) → contralateral hemiparesis + hemisensory loss + homonymous hemianopia.
• Weber syndrome (midbrain): CN III fascicle (ipsilateral ophthalmoplegia) + crus cerebri (contralateral hemiparesis).
• Foville syndrome (pons): CN VI nucleus or fascicle (ipsilateral lateral gaze palsy) + facial nerve fascicle (ipsilateral facial palsy) + corticospinal tract (contralateral hemiparesis).
• Wallenberg (lateral medulla): spinothalamic + spinal trigeminal + nucleus ambiguus + restiform body + vestibular + descending sympathetic — a remarkable convergence of pathways in one anatomic location.

🔍 Did You Know?

The distinction between discrete and system lesions has practical consequences that extend beyond academic taxonomy. A patient with insidious, symmetric progression of weakness affecting both upper motor neurons (hyperreflexia, spasticity) and lower motor neurons (atrophy, fasciculations) — across multiple regions, both bulbar and spinal — has a system disease (ALS), and an MRI looking for a single lesion will be unrevealing or distracting. Treatment, prognosis, and counseling differ profoundly. By contrast, a patient with sudden onset of weakness on one side has a discrete lesion, and an MRI will almost always show the cause. Recognizing the topographic pattern at the start determines whether we order an MRI looking for a focal lesion, an EMG looking for system motor neuron involvement, a metabolic workup looking for systemic vulnerability, or a genetic panel looking for a hereditary ataxia. The thoughtful application of topographic principles avoids the trap of imaging-driven workup that may show incidental findings while missing the actual disease.

Pitfalls and Pearls

• Localize to the lowest possible level first. A peripheral lesion masquerading as central disease is a common error.
• Recognize the discrete vs system distinction. It shapes imaging, ancillary testing, and counseling.
• Insidious symmetric progression points to a system process. Don’t keep imaging looking for one elusive lesion.
• Acute focal deficit points to a discrete process. Imaging is usually revealing.
• Crossed signs (ipsilateral CN, contralateral body) localize to brainstem.
• The intersection principle: lesions are usually where pathways cross. Multiple findings → look for the intersection.
• History tells you about tempo; exam tells you about location.
• System processes can have asymmetric onset (e.g., ALS often begins in one limb) but become symmetric over time.
• The hybrid pattern (MS, paraneoplastic, infection) requires entertaining both discrete and system possibilities.
• Imaging is not localization. The exam localizes; imaging confirms or characterizes. Imaging first invites pursuit of incidental findings.

References

1. Brazis PW, Masdeu JC, Biller J. Localization in Clinical Neurology. 7th ed. Wolters Kluwer; 2017.
2. Ropper AH, Samuels MA, Klein JP, Prasad S. Adams and Victor’s Principles of Neurology. 11th ed. McGraw-Hill; 2019.
3. Patten J. Neurological Differential Diagnosis. 2nd ed. Springer; 1996.
4. Campbell WW. DeJong’s The Neurologic Examination. 8th ed. Wolters Kluwer; 2019.
5. Posner JB, Saper CB, Schiff ND, Plum F. Plum and Posner’s Diagnosis of Stupor and Coma. 4th ed. Oxford University Press; 2007.